Personalized Medicine Biomarkers Market Size, Share, Trends, and Growth Forecast 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Personalized Medicine Biomarkers Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Regulatory Landscape
   2. Product Adoption Analysis
   3. Value Chain Analysis
   4. Key Deals and Mergers
   5. PESTLE Analysis
   6. Porter’s Five Force Analysis
4. Global Personalized Medicine Biomarkers Market Outlook:
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019-2024
      2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   3. Global Personalized Medicine Biomarkers Market Outlook: Biomarker Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Biomarker Type, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker Type, 2025 - 2032
         1. Genomic
         2. Proteomics
         3. Metabolic
         4. Others
      4. Market Attractiveness Analysis: Biomarker Type
   4. Global Personalized Medicine Biomarkers Market Outlook: Application
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
         1. Disease Diagnosis
         2. Drug Discovery & Development
         3. Therapeutic Monitoring
         4. Treatment Selection
         5. Others
      4. Market Attractiveness Analysis: Application
   5. Global Personalized Medicine Biomarkers Market Outlook: Disease Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Disease Indication, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025 - 2032
         1. Oncology
         2. Neurology
         3. Diabetes
         4. Autoimmune diseases
         5. Cardiology
         6. Others
      4. Market Attractiveness Analysis: Disease Indication
   6. Global Personalized Medicine Biomarkers Market Outlook: End User
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
      3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
         1. Pharmaceutical & Biotechnology Companies
         2. Hospitals & Clinics
         3. Diagnostic Laboratories
         4. Others
      4. Market Attractiveness Analysis: End User
5. Global Personalized Medicine Biomarkers Market Outlook: Region
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
   4. Market Attractiveness Analysis: Region
6. North America Personalized Medicine Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Application
      4. By Disease Indication
      5. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. Genomic
      2. Proteomics
      3. Metabolic
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Therapeutic Monitoring
      4. Treatment Selection
      5. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025 - 2032
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune diseases
      5. Cardiology
      6. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Hospitals & Clinics
      3. Diagnostic Laboratories
      4. Others
   8. Market Attractiveness Analysis
7. Europe Personalized Medicine Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Application
      4. By Disease Indication
      5. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. Genomic
      2. Proteomics
      3. Metabolic
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Therapeutic Monitoring
      4. Treatment Selection
      5. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025 - 2032
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune diseases
      5. Cardiology
      6. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Hospitals & Clinics
      3. Diagnostic Laboratories
      4. Others
   8. Market Attractiveness Analysis
8. East Asia Personalized Medicine Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Application
      4. By Disease Indication
      5. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. Genomic
      2. Proteomics
      3. Metabolic
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Therapeutic Monitoring
      4. Treatment Selection
      5. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025 - 2032
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune diseases
      5. Cardiology
      6. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Hospitals & Clinics
      3. Diagnostic Laboratories
      4. Others
   8. Market Attractiveness Analysis
9. South Asia & Oceania Personalized Medicine Biomarkers Market Outlook:
   1. Key Highlights
   2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Biomarker Type
      3. By Application
      4. By Disease Indication
      5. By End User
   3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
   4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker Type, 2025 - 2032
      1. Genomic
      2. Proteomics
      3. Metabolic
      4. Others
   5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
      1. Disease Diagnosis
      2. Drug Discovery & Development
      3. Therapeutic Monitoring
      4. Treatment Selection
      5. Others
   6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025 - 2032
      1. Oncology
      2. Neurology
      3. Diabetes
      4. Autoimmune diseases
      5. Cardiology
      6. Others
   7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
      1. Pharmaceutical & Biotechnology Companies
      2. Hospitals & Clinics
      3. Diagnostic Laboratories
      4. Others
   8. Market Attractiveness Analysis
10. Latin America Personalized Medicine Biomarkers Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Biomarker Type
       3. By Application
       4. By Disease Indication
       5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker Type, 2025 - 2032
       1. Genomic
       2. Proteomics
       3. Metabolic
       4. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       1. Disease Diagnosis
       2. Drug Discovery & Development
       3. Therapeutic Monitoring
       4. Treatment Selection
       5. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025 - 2032
       1. Oncology
       2. Neurology
       3. Diabetes
       4. Autoimmune diseases
       5. Cardiology
       6. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
       1. Pharmaceutical & Biotechnology Companies
       2. Hospitals & Clinics
       3. Diagnostic Laboratories
       4. Others
    8. Market Attractiveness Analysis
11. Middle East & Africa Personalized Medicine Biomarkers Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       1. By Country
       2. By Biomarker Type
       3. By Application
       4. By Disease Indication
       5. By End User
    3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    4. Current Market Size (US$ Mn) Analysis and Forecast, By Biomarker Type, 2025 - 2032
       1. Genomic
       2. Proteomics
       3. Metabolic
       4. Others
    5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       1. Disease Diagnosis
       2. Drug Discovery & Development
       3. Therapeutic Monitoring
       4. Treatment Selection
       5. Others
    6. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025 - 2032
       1. Oncology
       2. Neurology
       3. Diabetes
       4. Autoimmune diseases
       5. Cardiology
       6. Others
    7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
       1. Pharmaceutical & Biotechnology Companies
       2. Hospitals & Clinics
       3. Diagnostic Laboratories
       4. Others
    8. Market Attractiveness Analysis
12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Abbott Laboratories
          1. Overview
          2. Segments and Products
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. Bio-Rad Laboratories
       3. Danaher
       4. EKF Diagnostics Holdings
       5. F. Hoffmann-La Roche
       6. Illumina
       7. Merck
       8. Myriad Genetics
       9. QIAGEN
       10. Signosis
       11. Singulex
       12. Thermo Fisher Scientific
       13. Siemens Healthineers
       14. PerkinElmer Inc.
       15. Agilent Technologies, Inc.
       16. Meso Scale Diagnostics
       17. Enzo Biochem
       18. Lifesign LLC
       19. Guardant Health
       20. Nexus-Dx
       21. Proteome Sciences
       22. Almac Diagnostics
       23. Biocartis
13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations